| pubmed-article:16464945 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0042133 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0034833 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0521387 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0332197 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C1709060 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
| pubmed-article:16464945 | lifeskim:mentions | umls-concept:C1455381 | lld:lifeskim |
| pubmed-article:16464945 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16464945 | pubmed:dateCreated | 2006-4-7 | lld:pubmed |
| pubmed-article:16464945 | pubmed:abstractText | Asoprisnil, a selective progesterone (P4) receptor (PR) modulator (SPRM) with mixed P4 agonist/antagonist activities, reduces uterine leiomyoma volume in a dose-dependent manner in the presence of follicular phase estrogen concentrations. The evidence from clinical studies suggests that asoprisnil may directly target the uterine leiomyomata. | lld:pubmed |
| pubmed-article:16464945 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16464945 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16464945 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16464945 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:16464945 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:DeyD KDK | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:LuT NTN | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:ChenWeiW | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:YoshidaShigek... | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:MaruoTakeshiT | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:SasakiHirokoH | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:ChwaliszKrist... | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:OharaNoriyuki... | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:WangJiayinJ | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:MorikawaAkira... | lld:pubmed |
| pubmed-article:16464945 | pubmed:author | pubmed-author:DemannoDebora... | lld:pubmed |
| pubmed-article:16464945 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16464945 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:16464945 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16464945 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16464945 | pubmed:pagination | 1296-304 | lld:pubmed |
| pubmed-article:16464945 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:meshHeading | pubmed-meshheading:16464945... | lld:pubmed |
| pubmed-article:16464945 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16464945 | pubmed:articleTitle | A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. | lld:pubmed |
| pubmed-article:16464945 | pubmed:affiliation | Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe 650-0017, Japan. | lld:pubmed |
| pubmed-article:16464945 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16464945 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16464945 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16464945 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16464945 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16464945 | lld:pubmed |
